Conclusion: Eltd1 knockdown affects tumour vasculature, particularly in inducible models suggesting that monoclonal antibodies targeted the calcium binding EGF domain should be considered for further therapeutic development. The gene discussed is ADGRL4; the disease is neoplasm.